The exosome and extracellular vesicles (EV) fields are on the verge of groundbreaking clinical and commercial breakthroughs with therapeutic progress hailed from key biopharma including Rion, Direct Biologics, Aegle Therapeutics, Aruna Bio, EXO Biologics, and more! Showcasing the biopharma's industry advancements in 2025, the 7th Exosome-Based Therapeutics Development Summit returns to Boston, with never-before-seen data, covering the end-to-end from discovery through to optimized characterization, scalable manufacturing and clinical output, as the only industry-dedicated Summit to bridge the gap between science and business towards effective regenerative and precision medicines.